Kouman Kouamé Bouatini Angélo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kouman Kouamé Bouatini Angélo has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Allico Joseph Djaman
Health and Biology, Félix Houphouët-Boigny University, Abidjan, Cote d’Ivoire;Fundamental and Medical Biochemistry, Pasteur Institute of Cote d'Ivoire, Abidjan, Cote d'Ivoire
2 shared publications - Dagnogo Oléfongo
Biosciences Training and Research Unit (UFR), Felix Houphouët-Boigny University, Abidjan, Côte d'Ivoire; Department of Parasitology-Mycology, Pasteur Institute of Côte d'Ivoire, Abidjan, Côte d'Ivoire
2 shared publications - Dougba Noel Dago
Department of Genetics and Biochemistry, Peleforo GON COULIBALY University, Korhogo, Côte d’Ivoire
2 shared publications Adji Gbessi Eric
1 shared publicationAko Ako Aristide Bérenger
1 shared publicationAssi Serge-Brice
1 shared publication
Latest Publications
- Open Access
- 22 January 2025
- Published by Science Publishing Group in International Journal of Genetics and Genomics
- Vol. 13 (1) , 10-19
Polymorphism of the rs12255372 Allele of the TCF7L2 Gene Associated with Predisposition to Type 2 Diabete Using SNP Markers in a Population in the North of the Côte d’Ivoire
Background : Type 2 diabetes (T2D) is a chronic metabolic disease characterised by hyperglycaemia due to insulin resistance and impaired insulin secretion. Genetic and environmental factors can influence predisposition to this disease. Genetic predisposition plays a significant role in the risk of developing the disease, and the TCF7L2 (T-Cell Factor-Like 2) gene is one of the main genes associated with type 2 diabetes. Objective: The aim of this study was to investigate the prevalence of the rs12255372 (G/T) polymorphism in TCF7L2, a gene associated with the risk of type 2 diabete (T2D) in the Ivorian population in the north of Côte d'Ivoire. Methodology : We included a total of 75 participants, 50 with type 2 diabete and 25 healthy subjects, for various anthropometric, clinical and genetic parameters. Participants were recruited from the Korhogo Regional Hospital. After obtaining consent, a blood sample was taken from each participant for glycaemia measurement and confetti realization for molecular biology. Genomic DNA extracted from the confetti was used to perform TCF7L2 gene genotyping using allele-specific PCR. Results : Analysis of the prevalence of the T allele of the SNP rs12255372 showed a statistically significant association between type 2 diabetic patients and non-diabetics (p≤0.05). The analysis revealed a genotypic prevalence of the rs12255372 variant of the TT allele significantly more expressed in non-diabetics (52%) compared with diabetics (26%) (p=0.03, z=2.23). Conclusion : This study revealed a high prevalence of the rs12255372 genetic variant of the TCF7L2 gene in non-diabetic populations in the north of Côte d'Ivoire, suggesting a significant predisposition to types 2 diabetes and the involvement of other factors, such as environmental conditions, lifestyle habits and genetic interactions in the development of type 2 diabetes in healthy subjects carrying the TT allele of the SNP rs12255372 of the TCF7L2 gene.
- 22 January 2025
- Published by Science Publishing Group in International Journal of Genetics and Genomics
- Vol. 13 (1) , 10-19
Open AccessPolymorphism of the rs12255372 Allele of the TCF7L2 Gene Associated with Predisposition to Type 2 Diabete Using SNP Markers in a Population in the North of the Côte d’Ivoire
Background : Type 2 diabetes (T2D) is a chronic metabolic disease characterised by hyperglycaemia due to insulin resistance and impaired insulin secretion. Genetic and environmental factors can influence predisposition to this disease. Genetic predisposition plays a significant role in the risk of developing the disease, and the TCF7L2 (T-Cell Factor-Like 2) gene is one of the main genes associated with type 2 diabetes. Objective: The aim of this study was to investigate the prevalence of the rs12255372 (G/T) polymorphism in TCF7L2, a gene associated with the risk of type 2 diabete (T2D) in the Ivorian population in the north of Côte d'Ivoire. Methodology : We included a total of 75 participants, 50 with type 2 diabete and 25 healthy subjects, for various anthropometric, clinical and genetic parameters. Participants were recruited from the Korhogo Regional Hospital. After obtaining consent, a blood sample was taken from each participant for glycaemia measurement and confetti realization for molecular biology. Genomic DNA extracted from the confetti was used to perform TCF7L2 gene genotyping using allele-specific PCR. Results : Analysis of the prevalence of the T allele of the SNP rs12255372 showed a statistically significant association between type 2 diabetic patients and non-diabetics (p≤0.05). The analysis revealed a genotypic prevalence of the rs12255372 variant of the TT allele significantly more expressed in non-diabetics (52%) compared with diabetics (26%) (p=0.03, z=2.23). Conclusion : This study revealed a high prevalence of the rs12255372 genetic variant of the TCF7L2 gene in non-diabetic populations in the north of Côte d'Ivoire, suggesting a significant predisposition to types 2 diabetes and the involvement of other factors, such as environmental conditions, lifestyle habits and genetic interactions in the development of type 2 diabetes in healthy subjects carrying the TT allele of the SNP rs12255372 of the TCF7L2 gene.
- Open Access
- 8 July 2024
- Published by Science Publishing Group in International Journal of Microbiology and Biotechnology
- Vol. 9 (3) , 68-78
Assessment of Saliva and Urine Performance for Antimalarial Drug Resistance Molecular Markers Study
Background : The malaria diagnostic tools developed to date require blood to be taken. However, certain groups in the population are reluctant to take blood samples because of their cultural habits (blood taboo), or because of the fear associated with the trauma of the injection, especially when the sample is taken repeatedly. Saliva and urine, which are not very invasive to collect, have not been widely used for malaria diagnosis. The aim of this study is to assess the performance of saliva and urine in detecting molecular markers of Plasmodium falciparum resistance to antimalarial drugs. Methodology : Blood, urine and saliva samples were collected in three different localities from 94 patients over 2 years of age with microscopically confirmed Plasmodium falciparum uncomplicated malaria. P. falciparum genomic DNA (Deoxyribonucleic acid) was then extracted and amplified using primers specific for the Pfcrt (Plasmodium falciparum Chloroquine Resistance Transporter), Pfdhfr (Plasmodium falciparum dihydrofolate reductase) and PfK13 propeller (Plasmodium falciparum Kelch13 propeller) genes. The amplification products were processed by electrophoresis and analyzed against blood, saliva and urine samples. A multivariate statistical analysis in R programming environment was performed aiming to assess the performance of blood, saliva and urine samples in detecting molecular markers of P. falciparum resistance. Results : Agarose gel electrophoresis of the amplification products of each gene detected the Pfcrt genes at 80.85% (76/94), Pfdhfr at 95.74% (90/94) and PfK13 Propeller at 98.93% (93/94) in blood. In saliva, gene detection levels were 50% (47/94), 69.14% (65/94) and 4.26% (4/94) respectively for the K13 propeller, Pfdhfr and Pfcrt genes. Unlike the Pfcrt gene, which was not detected, 45.74% (43/94) and 38.30% (36/94) of PfK13 Propeller and pfdhfr genes respectively were detected in urine. Taking blood as the reference biological sample, statistical analysis showed that unlike urine, saliva exhibited a detection performance for molecular markers of antimalarial drug resistance ( pfcrt, pfdhfr , pfK13 propeller) close to that of blood (p < 0.05). The performance of saliva and urine was also assessed on the basis of the detection of the molecular markers pfdhfr , pfcrt and pfK13 using ROC ( receiver operational characteristic ) analysis. The data revealed a high sensitivity of saliva compared with urine in the detection of the pfdhfr , pfcrt and pfK13 propeller genes. Conclusion : The levels of detection of molecular markers of antimalarial drug resistance studied in saliva are close to those in blood. Saliva is a high-performance biological product that could potentially be used as an alternative non-invasive sample for the study of molecular markers of Plasmodium falciparum resistance to antimalarial drugs.
- 8 July 2024
- Published by Science Publishing Group in International Journal of Microbiology and Biotechnology
- Vol. 9 (3) , 68-78
Open AccessAssessment of Saliva and Urine Performance for Antimalarial Drug Resistance Molecular Markers Study
Background : The malaria diagnostic tools developed to date require blood to be taken. However, certain groups in the population are reluctant to take blood samples because of their cultural habits (blood taboo), or because of the fear associated with the trauma of the injection, especially when the sample is taken repeatedly. Saliva and urine, which are not very invasive to collect, have not been widely used for malaria diagnosis. The aim of this study is to assess the performance of saliva and urine in detecting molecular markers of Plasmodium falciparum resistance to antimalarial drugs. Methodology : Blood, urine and saliva samples were collected in three different localities from 94 patients over 2 years of age with microscopically confirmed Plasmodium falciparum uncomplicated malaria. P. falciparum genomic DNA (Deoxyribonucleic acid) was then extracted and amplified using primers specific for the Pfcrt (Plasmodium falciparum Chloroquine Resistance Transporter), Pfdhfr (Plasmodium falciparum dihydrofolate reductase) and PfK13 propeller (Plasmodium falciparum Kelch13 propeller) genes. The amplification products were processed by electrophoresis and analyzed against blood, saliva and urine samples. A multivariate statistical analysis in R programming environment was performed aiming to assess the performance of blood, saliva and urine samples in detecting molecular markers of P. falciparum resistance. Results : Agarose gel electrophoresis of the amplification products of each gene detected the Pfcrt genes at 80.85% (76/94), Pfdhfr at 95.74% (90/94) and PfK13 Propeller at 98.93% (93/94) in blood. In saliva, gene detection levels were 50% (47/94), 69.14% (65/94) and 4.26% (4/94) respectively for the K13 propeller, Pfdhfr and Pfcrt genes. Unlike the Pfcrt gene, which was not detected, 45.74% (43/94) and 38.30% (36/94) of PfK13 Propeller and pfdhfr genes respectively were detected in urine. Taking blood as the reference biological sample, statistical analysis showed that unlike urine, saliva exhibited a detection performance for molecular markers of antimalarial drug resistance ( pfcrt, pfdhfr , pfK13 propeller) close to that of blood (p < 0.05). The performance of saliva and urine was also assessed on the basis of the detection of the molecular markers pfdhfr , pfcrt and pfK13 using ROC ( receiver operational characteristic ) analysis. The data revealed a high sensitivity of saliva compared with urine in the detection of the pfdhfr , pfcrt and pfK13 propeller genes. Conclusion : The levels of detection of molecular markers of antimalarial drug resistance studied in saliva are close to those in blood. Saliva is a high-performance biological product that could potentially be used as an alternative non-invasive sample for the study of molecular markers of Plasmodium falciparum resistance to antimalarial drugs.
- 20 February 2023
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 12 (2) , 125-134
Analysis of Plasmodium falciparum Resistance to Chloroquine in Côte d'Ivoire after 20 Years: High Prevalence of Wild Strains
Malaria is a major public health problem worldwide, especially in Africa, where antimalarial drug-resistant strains are spreading. In Côte d'Ivoire, Dihydro-artemisinine Piperaquine (DHA-PPQ) has been included in the policy for simple malaria management, but key mutations of the pfcrt gene are being studied to determine the mutation points that modulate Plasmodium falciparum resistance to Piperaquine. Genomic DNA from 158 patients from the five study sites with P.falciparum malaria was extracted using Chelex 5% tween. Conventional PCR amplification of the pfcrt gene was followed by Sanger sequencing of the amplificates on the Sanger sequencing platform of the CRCHU of Quebec (Canada). Comparison of different proportions was carried out using Rstudio software version 4.1.3. Analysis of individual alleles showed a prevalence of wild strain alleles over mutant alleles at all study sites. The K76T mutation was found at relatively low prevalences at the sites: 4.5% (1/22) in Bouaké; 10% (2/20) in Yamoussoukro; 18.5% (4/20) in Ayame; 20% (5/27) in Man and 34.8% (24/69) in Anonkoua-koute. Analysis of the distribution of the wild strain haplotype (CVMNK) of the pfcrt gene showed a high proportion (55-80% prevalence) compared to mutant strain haplotypes (1-20% prevalence). The high prevalence of the CVMNK haplotype across all sentinel sites supports the potential for regained sensitivity to CQ in the treatment of simple malaria. Therefore, continued molecular surveillance and in vitro analysis of pfcrt gene polymorphism mutations is highly recommended.
- 20 February 2023
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 12 (2) , 125-134
Analysis of Plasmodium falciparum Resistance to Chloroquine in Côte d'Ivoire after 20 Years: High Prevalence of Wild Strains
Malaria is a major public health problem worldwide, especially in Africa, where antimalarial drug-resistant strains are spreading. In Côte d'Ivoire, Dihydro-artemisinine Piperaquine (DHA-PPQ) has been included in the policy for simple malaria management, but key mutations of the pfcrt gene are being studied to determine the mutation points that modulate Plasmodium falciparum resistance to Piperaquine. Genomic DNA from 158 patients from the five study sites with P.falciparum malaria was extracted using Chelex 5% tween. Conventional PCR amplification of the pfcrt gene was followed by Sanger sequencing of the amplificates on the Sanger sequencing platform of the CRCHU of Quebec (Canada). Comparison of different proportions was carried out using Rstudio software version 4.1.3. Analysis of individual alleles showed a prevalence of wild strain alleles over mutant alleles at all study sites. The K76T mutation was found at relatively low prevalences at the sites: 4.5% (1/22) in Bouaké; 10% (2/20) in Yamoussoukro; 18.5% (4/20) in Ayame; 20% (5/27) in Man and 34.8% (24/69) in Anonkoua-koute. Analysis of the distribution of the wild strain haplotype (CVMNK) of the pfcrt gene showed a high proportion (55-80% prevalence) compared to mutant strain haplotypes (1-20% prevalence). The high prevalence of the CVMNK haplotype across all sentinel sites supports the potential for regained sensitivity to CQ in the treatment of simple malaria. Therefore, continued molecular surveillance and in vitro analysis of pfcrt gene polymorphism mutations is highly recommended.